Praxis Precision Medicines (PRAX) Operating Expenses (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Operating Expenses of $105.9 million for Q1 2026, up 41.66% year-over-year from $74.7 million in Q1 2025, and up 9.08% quarter-over-quarter from $97.0 million in Q4 2025.
Praxis Precision Medicines (PRAX) Operating Expenses (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Operating Expenses history runs 8 years deep, the most recent figure standing at $105.9 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 41.66% year-over-year to $105.9 million; the TTM figure through Mar 2026 stood at $357.3 million (up 48.19% YoY), while the FY2025 annual figure was $326.2 million, up 56.29% from the prior year.
- Operating Expenses for Q1 2026 stood at $105.9 million, up from $97.0 million in the prior quarter.
- The five-year high for Operating Expenses was $105.9 million in Q1 2026, with the low at $26.0 million in Q3 2023.
- The 5-year median for Operating Expenses is $57.1 million (2024), against an average of $57.9 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 43.68% in 2023, then jumped 152.18% in 2024.
- Praxis Precision Medicines' Operating Expenses stood at $41.5 million in 2022, then plunged by 31.68% to $28.3 million in 2023, then surged by 152.18% to $71.4 million in 2024, then jumped by 35.88% to $97.0 million in 2025, then climbed by 9.08% to $105.9 million in 2026.
- Business Quant data shows PRAX's Operating Expenses at $105.9 million in Q1 2026, $97.0 million in Q4 2025, and $78.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | 96.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.90 Mn |
| Mar 31, 2026 | 105.86 Mn |
| Dec 31, 2025 | 97.04 Mn |
| Sep 30, 2025 | 78.36 Mn |
| Jun 30, 2025 | 76.07 Mn |
| Mar 31, 2025 | 74.73 Mn |
| Dec 31, 2024 | 71.42 Mn |
| Sep 30, 2024 | 57.14 Mn |
| Jun 30, 2024 | 37.85 Mn |
| Mar 31, 2024 | 42.32 Mn |
| Dec 31, 2023 | 28.32 Mn |
| Sep 30, 2023 | 25.98 Mn |
| Jun 30, 2023 | 35.74 Mn |
| Mar 31, 2023 | 38.77 Mn |
| Dec 31, 2022 | 41.45 Mn |
| Sep 30, 2022 | 44.29 Mn |
| Jun 30, 2022 | 60.39 Mn |
| Mar 31, 2022 | 68.85 Mn |
| Dec 31, 2021 | 58.66 Mn |
| Sep 30, 2021 | 44.77 Mn |